Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04494945 · ClinicalTrials.gov registry record · NA

Identifying and Caring for Individuals With Inherited Cancer Syndrome

A NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, sponsored by OHSU Knight Cancer Institute.

Recruiting
Registry status
NA
Development phase
27,500
Enrollment target
2
Study locations

NCT04494945 is a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm that is actively recruiting participants, run by OHSU Knight Cancer Institute. The registered enrollment target is 27,500 participants, above the 985-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (2692% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04494945, a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, is actively recruiting participants, sponsored by OHSU Knight Cancer Institute.

RECRUITING
Registry status
NA
Development phase
27,500 participants
Enrollment target
2
Study locations

Study Summary

This trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testing to the general public. Researchers hope to learn the value of providing broad, public-wide testing for high risk cancer types (like hereditary breast and ovarian cancer or Lynch syndromes) instead of only testing people whose families are known to be high risk.

Conditions Studied

Malignant Solid Neoplasm Hematopoietic and Lymphoid System Neoplasm Lynch Syndrome Breast Ductal Carcinoma In Situ Hereditary Neoplastic Syndrome BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Survey Administration
  • OTHER Genetic Testing
  • OTHER Genetic Counseling

Study Locations (2)

Oregon

  • Providence Portland Medical Center - Portland
  • OHSU Knight Cancer Institute - Portland

Trial Details

FieldValue
Enrollment Target 27,500 participants
Start Date 2020-03-09
Est. Completion 2026-03-31
Phase NA

Sponsor

OHSU Knight Cancer Institute

211 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04494945

The ClinicalTrials.gov registry entry for NCT04494945 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 27,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 985-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (2692% higher). The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Biospecimen Collection is the first listed.

NCT04494945 reports 2 study locations spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT04494945 about?

NCT04494945 is a clinical study titled "Identifying and Caring for Individuals With Inherited Cancer Syndrome". This trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testing to the general public. Researchers hope to learn the value of providing broad, public-wide testing for high risk cancer types (like heredi...

What is the current status of trial NCT04494945?

This trial is currently recruiting. It is a NA study. The enrollment target is 27,500 participants. The study started on 2020-03-09. Estimated completion is 2026-03-31.

What conditions does trial NCT04494945 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm, Lynch Syndrome, Breast Ductal Carcinoma In Situ, Hereditary Neoplastic Syndrome.

What interventions are being tested in trial NCT04494945?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Survey Administration (OTHER), Genetic Testing (OTHER), Genetic Counseling (OTHER).

Who is sponsoring clinical trial NCT04494945?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04494945 being conducted?

This trial has 2 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Malignant Solid Neoplasm

All registered trials for this condition

Hematopoietic and Lymphoid System Neoplasm

All registered trials for this condition

Oregon

All trials with a study site in Oregon

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.